← FDA Drug Approvals (Drugs@FDA)

GLYCOPYRROLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NIVAGEN PHARMS INC · Approved 2021-10-13

Drug application

FDA Application #

ANDA212591

Application type

Abbreviated New Drug Application (Generic)

Brand name

GLYCOPYRROLATE

Generic name

GLYCOPYRROLATE

Active ingredients

GLYCOPYRROLATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

NIVAGEN PHARMS INC

Manufacturer

Nivagen Pharmaceuticals, Inc.

First approval

2021-10-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown